Talkspace (TALK) Q2 2024 earnings summary

Executive summary

• Achieved 29% year-over-year revenue growth to $46.1 million in Q2 2024, led by 62% growth in Payor revenue and 20% growth in Direct to Enterprise revenue, partially offset by a 28% decline in Consumer revenue.

• Net loss narrowed to $0.5 million from $4.7 million year-over-year; Adjusted EBITDA reached $1.2 million, marking the second consecutive quarter of adjusted EBITDA profitability.

• Expanded covered lives to 145 million, up 33% year-over-year, and launched Medicare in 12 states and TRICARE covering 6 million military lives.

• Provider network grew 34% year-over-year to over 5,700 therapists, supporting improved patient access and provider productivity.

• Continued investment in product innovation, AI features, and therapist efficiency, with brand awareness rising to over 30%.

Financial highlights

• Q2 2024 revenue: $46.1 million, up 29% year-over-year; gross profit: $21.0 million, up 18% year-over-year; gross margin at 45.5%, down from 50% due to payer mix shift.

• Adjusted EBITDA: $1.2 million, a $5.2 million improvement from prior year.

• GAAP net loss: $0.5 million, a $4.2 million improvement year-over-year; net loss per share improved to $(0.00) from $(0.03).

• Operating expenses (GAAP): $24.4 million, up 1% year-over-year; normalized OpEx down $2 million.

• Ended quarter with $114.9 million in cash and equivalents; no debt; $8 million in share repurchases during Q2.

Outlook and guidance

• 2024 revenue guidance: $185–$195 million, representing 23–30% year-over-year growth; Adjusted EBITDA guidance: $4–$8 million.

• Medicare rollout expected in all 50 states by year-end, with first Medicare Advantage plan launching in Q4.

• Medicare and TRICARE launches expected to be modest contributors in 2024, with more material impact in 2025.

• Direct enterprise revenue expected to grow in high teens or better year-over-year.

• Sufficient liquidity to fund operations for at least the next 12 months and foreseeable future.